CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-07 | Keresty Georgia Director | Grant or award · Director Stock Option (Right to Buy) | +51,000 | 51,000 | ||
| 2022-06-07 | Kahn Clare Director | Grant or award · Director Stock Option (Right to Buy) | +51,000 | 51,000 | ||
| 2022-06-07 | Kahn Clare Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-06-07 | Huffines Robert Luther Director | Grant or award · Director Stock Option (Right to Buy) | +51,000 | 51,000 | ||
| 2022-06-07 | Freed Martin I Director | Grant or award · Director Stock Option (Right to Buy) | +51,000 | 51,000 | ||
| 2022-06-07 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Director Stock Option (Right to Buy) | +51,000 | 51,000 | ||
| 2022-06-07 | Stone Adam Leo Director | Grant or award · Stock Option (Right to Buy) | +51,000 | 51,000 | ||
| 2022-06-07 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Stock Option (Right to Buy) | +51,000 | 51,000 | ||
| 2022-05-02 | Morris Carl Ashley Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +296,000 | 296,000 | ||
| 2022-05-02 | Ganot Ilan CEO & President | Grant or award · Restricted Stock Units | +46,600 | 46,600 | ||
| 2022-05-02 | Brennan Erin Powers Chief Legal Officer, Secretary | Grant or award · Employee Stock Option (Right to Buy) | +254,000 | 254,000 | ||
| 2022-04-03 | SMITH IAN F Director | Option exercise | +24,313 | 294,583 | ||
| 2022-04-03 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −24,313 | 72,937 | ||
| 2022-03-14 | Morris Carl Ashley Chief Scientific Officer | Sale | −11,269 | $1.10 | $12K | 266,605 |
| 2022-03-14 | Morris Carl Ashley Chief Scientific Officer | Sale | −11,396 | $1.10 | $13K | 255,209 |
| 2022-03-14 | Schneider Joel Solomon Zev Chief Operating Officer | Sale | −15,232 | $1.10 | $17K | 251,542 |
| 2022-03-14 | Schneider Joel Solomon Zev Chief Operating Officer | Sale | −15,272 | $1.10 | $17K | 236,270 |
| 2022-02-10 | Ganot Ilan CEO & President | Sale | −463 | $1.12 | $519 | 2,518 |
| 2022-01-27 | Brennan Erin Powers Chief Legal Officer, Secretary | Grant or award · Restricted Stock Units | +81,250 | 81,250 | ||
| 2022-01-27 | Schneider Joel Solomon Zev Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +180,000 | 180,000 |
Page 20 of 21 · 403 trades